1. Home
  2. RPRX vs PKG Comparison

RPRX vs PKG Comparison

Compare RPRX & PKG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPRX
  • PKG
  • Stock Information
  • Founded
  • RPRX 1996
  • PKG 1867
  • Country
  • RPRX United States
  • PKG United States
  • Employees
  • RPRX N/A
  • PKG N/A
  • Industry
  • RPRX Biotechnology: Pharmaceutical Preparations
  • PKG Containers/Packaging
  • Sector
  • RPRX Health Care
  • PKG Consumer Discretionary
  • Exchange
  • RPRX Nasdaq
  • PKG Nasdaq
  • Market Cap
  • RPRX 16.2B
  • PKG 18.5B
  • IPO Year
  • RPRX 2020
  • PKG 2000
  • Fundamental
  • Price
  • RPRX $39.60
  • PKG $199.46
  • Analyst Decision
  • RPRX Strong Buy
  • PKG Buy
  • Analyst Count
  • RPRX 3
  • PKG 7
  • Target Price
  • RPRX $46.00
  • PKG $233.00
  • AVG Volume (30 Days)
  • RPRX 2.9M
  • PKG 863.3K
  • Earning Date
  • RPRX 11-05-2025
  • PKG 10-22-2025
  • Dividend Yield
  • RPRX 2.16%
  • PKG 2.52%
  • EPS Growth
  • RPRX N/A
  • PKG 15.38
  • EPS
  • RPRX 1.60
  • PKG 9.90
  • Revenue
  • RPRX $2,349,553,000.00
  • PKG $8,771,800,000.00
  • Revenue This Year
  • RPRX $36.16
  • PKG $9.11
  • Revenue Next Year
  • RPRX $2.04
  • PKG $12.38
  • P/E Ratio
  • RPRX $25.42
  • PKG $20.01
  • Revenue Growth
  • RPRX 3.69
  • PKG 7.30
  • 52 Week Low
  • RPRX $24.05
  • PKG $172.72
  • 52 Week High
  • RPRX $41.24
  • PKG $250.82
  • Technical
  • Relative Strength Index (RSI)
  • RPRX 64.25
  • PKG 41.84
  • Support Level
  • RPRX $36.03
  • PKG $192.82
  • Resistance Level
  • RPRX $41.24
  • PKG $200.62
  • Average True Range (ATR)
  • RPRX 1.16
  • PKG 5.51
  • MACD
  • RPRX 0.35
  • PKG -0.38
  • Stochastic Oscillator
  • RPRX 69.20
  • PKG 28.93

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

About PKG Packaging Corporation of America

Packaging Corp. of America is the third-largest containerboard and corrugated packaging manufacturer in the United States. It produces over 5 million tons of containerboard annually. The company's share of the domestic containerboard market is roughly 10%. PCA differentiates itself from larger competitors by focusing on smaller customers and operating with a high degree of flexibility.

Share on Social Networks: